Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - SELECTA BIOSCIENCES INCexhibit32212312019.htm
EX-32.1 - EXHIBIT 32.1 - SELECTA BIOSCIENCES INCexhibit32112312019.htm
EX-31.2 - EXHIBIT 31.2 - SELECTA BIOSCIENCES INCexhibit31212312019.htm
EX-31.1 - EXHIBIT 31.1 - SELECTA BIOSCIENCES INCexhibit31112312019.htm
EX-10.7(I) - EXHIBIT 10.7(I) - SELECTA BIOSCIENCES INCexhibit107imassachuset.htm
EX-4.10 - EXHIBIT 4.10 - SELECTA BIOSCIENCES INCexhibit410descriptiono.htm
10-K - 10-K - SELECTA BIOSCIENCES INCselectabiosciences10-k.htm


Exhibit 23.1



Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)
Registration Statement (Form S-8, File No. 333-212215) pertaining to the 2008 Stock Incentive Plan, as amended, the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Selecta Biosciences, Inc.,

(2)
Registration Statement (Form S-8, File No. 333-224109) pertaining to the 2016 Incentive Awards Plan and the 2016 Employee Stock Purchase Plan,

(3)
Registration Statement (Form S-8, File No. 333-228264) pertaining to the 2018 Employment Inducement Incentive Award Plan,

(4)
Registration Statement (Form S-8, File No. 333-230501) pertaining to the 2018 Employment Inducement Incentive Award Plan,

(5)
Registration Statement (Form S-3, File No. 333-219262),

(6)
Registration Statement (Form S-3, File No. 333-219900), and

(7)
Registration Statement (Form S-3, File No. 333-236147);

of our report dated March 12, 2020 with respect to the consolidated financial statements of Selecta Biosciences, Inc. included in this Annual Report (Form 10-K) of Selecta Biosciences, Inc. for the year ended December 31, 2019.

/s/ Ernst & Young LLP

Boston, Massachusetts
March 12, 2020